218 related articles for article (PubMed ID: 1473873)
21. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
22. In vitro release of amoxycillin from lipophilic suppositories.
Webster JA; Dowse R; Walker RB
Drug Dev Ind Pharm; 1998 Apr; 24(4):395-9. PubMed ID: 9876601
[TBL] [Abstract][Full Text] [Related]
23. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
24. Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain.
Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
J Clin Pharmacol; 1995 Jul; 35(7):666-72. PubMed ID: 7560246
[TBL] [Abstract][Full Text] [Related]
25. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
[TBL] [Abstract][Full Text] [Related]
26. Further development of a morphine hydrogel suppository.
Cole L; Hanning CD; Robertson S; Quinn K
Br J Clin Pharmacol; 1990 Dec; 30(6):781-6. PubMed ID: 2288824
[TBL] [Abstract][Full Text] [Related]
27. [Morphine hydrochloride suppositories. I. Bioavailability of morphine hydrochloride suppositories in rats].
Tan T; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):426-33. PubMed ID: 2213529
[TBL] [Abstract][Full Text] [Related]
28. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
Bećirević M; Petricić V; Kallay N
Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
[TBL] [Abstract][Full Text] [Related]
30. [A patient with hepatoma and hepatic cirrhosis showing abnormally high blood morphine concentration after periodical suppository administration].
Kameue T; Matoba M; Ogawa H
Masui; 1994 Jan; 43(1):126-9. PubMed ID: 8309046
[TBL] [Abstract][Full Text] [Related]
31. Influence of the hydrophilicity of suppository bases on rectal absorption of carprofen, a lipophilic nonsteroidal anti-inflammatory drug.
Schmitt M; Guentert TW
J Pharm Sci; 1990 Apr; 79(4):359-63. PubMed ID: 2352151
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
33. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
34. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
35. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
36. The morphine hydrogel suppository. A new sustained release rectal preparation.
Hanning CD; Vickers AP; Smith G; Graham NB; McNeil ME
Br J Anaesth; 1988 Aug; 61(2):221-7. PubMed ID: 3415895
[TBL] [Abstract][Full Text] [Related]
37. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
38. Utility of a rectal suppository containing the antiepileptic drug zonisamide.
Nagatomi A; Mishima M; Tsuzuki O; Ohdo S; Higuchi S
Biol Pharm Bull; 1997 Aug; 20(8):892-6. PubMed ID: 9300137
[TBL] [Abstract][Full Text] [Related]
39. Comparative bioavailability of a morphine suppository given rectally and in a colostomy.
Højsted J; Rubeck-Petersen K; Rask H; Bigler D; Broen Christensen C
Eur J Clin Pharmacol; 1990; 39(1):49-50. PubMed ID: 2276388
[TBL] [Abstract][Full Text] [Related]
40. The release of isoconazole nitrate from different suppository bases: in-vitro dissolution, physicochemical and microbiological studies.
Asikoglu M; Ertan G; Cosar G
J Pharm Pharmacol; 1995 Sep; 47(9):713-6. PubMed ID: 8583380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
